Stockscreener 앱 받기
134.63
0.93%
1.245
시간 외 거래:
134.63
전일 마감가:
$133.38
열려 있는:
$134.09
하루 거래량:
170.23K
Relative Volume:
0.34
시가총액:
$4.30B
수익:
$560.03M
순이익/손실:
$-150.66M
주가수익비율:
-27.70
EPS:
-4.86
순현금흐름:
$-87.43M
1주 성능:
-1.73%
1개월 성능:
-10.81%
6개월 성능:
+21.28%
1년 성능:
+34.43%
1일 변동 폭
$133.69
$135.20
1주일 범위
$132.21
$138.41
52주 변동 폭
$55.92
$157.13
Irhythm Technologies Inc Stock (IRTC) Company Profile
명칭
Irhythm Technologies Inc
전화
415-632-5700
주소
699 8TH STREET, San Francisco, CA
IRTC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IRTC
Irhythm Technologies Inc
|
134.63 | 4.26B | 560.03M | -150.66M | -87.43M | -4.86 |
|
ABT
Abbott Laboratories
|
125.83 | 218.75B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.76 | 152.62B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
400.93 | 151.01B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.01 | 117.43B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.91 | 44.76B | 5.54B | 4.18B | 623.10M | 7.00 |
Irhythm Technologies Inc Stock (IRTC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-02 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-12-03 | 재개 | Wells Fargo | Equal Weight |
| 2024-10-04 | 개시 | Goldman | Neutral |
| 2024-06-20 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-02-07 | 개시 | Wells Fargo | Overweight |
| 2022-11-07 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2022-06-09 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-04-06 | 개시 | Wolfe Research | Underperform |
| 2022-02-24 | 업그레이드 | Needham | Hold → Buy |
| 2022-01-18 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-01-12 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-01-11 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-12-21 | 재개 | Canaccord Genuity | Buy |
| 2021-12-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-12-15 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-06-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-04-13 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2021-04-12 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-02-26 | 다운그레이드 | Colliers Securities | Buy → Neutral |
| 2021-01-29 | 재확인 | Needham | Hold |
| 2020-11-17 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-09-11 | 개시 | Needham | Hold |
| 2020-09-02 | 개시 | Robert W. Baird | Neutral |
| 2020-08-07 | 업그레이드 | Colliers Securities | Neutral → Buy |
| 2020-08-05 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-06 | 개시 | BTIG Research | Buy |
| 2020-01-10 | 개시 | William Blair | Outperform |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2019-10-22 | 개시 | Oppenheimer | Perform |
| 2019-02-20 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2018-09-13 | 재확인 | Canaccord Genuity | Buy |
| 2018-09-06 | 개시 | Chardan Capital Markets | Buy |
| 2018-08-02 | 업그레이드 | Dougherty & Company | Sell → Neutral |
| 2018-07-16 | 다운그레이드 | Dougherty & Company | Neutral → Sell |
| 2017-12-01 | 개시 | Dougherty & Company | Neutral |
모두보기
Irhythm Technologies Inc 주식(IRTC)의 최신 뉴스
iRhythm Technologies Inc. Stock Analysis and ForecastFree Stock Market Knowledge Sharing - Autocar Professional
What analysts say about iRhythm Technologies Inc. stockSuperior returns - Autocar Professional
What drives iRhythm Technologies Inc. stock pricePhenomenal returns - Autocar Professional
Tempus AI Gains FDA Nod Amid Booming AI ECG Market Momentum - TradingView
Is iRhythm Technologies Inc. a good long term investmentOutstanding capital growth - jammulinksnews.com
Would iRhythm Technologies (NASDAQ:IRTC) Be Better Off With Less Debt? - simplywall.st
1 Russell 2000 Stock Worth Your Attention and 2 Facing Challenges - Yahoo Finance
Sanofi India Limited (SANOFI) Hits 52 Week HighOutstanding risk-reward balance - Autocar Professional
TEM Shares Surge on New AI Breakthrough: Should Investors Jump In? - MSN
iRhythm Technologies to Report Second Quarter 2025 Financial Results on July 31, 2025 - The Manila Times
ECG Sensor Patches Market worth $2.32 billion by 2032 with 12.0% CAGR | MarketsandMarkets™ - PR Newswire
Robert W. Baird Maintains Buy Rating on Irhythm Technologies with $160 Price Target - AInvest
(IRTC) Technical Data - news.stocktradersdaily.com
IRHYTHM INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc.IRTC - Eastern Progress
Global Mobile ECG Devices Market Set for Rapid Expansion at 11.7% CAGR by 2032 | AliveCor, Beurer UK Ltd., Omron - The Globe and Mail
Researchers Find Wearables Help Detect Post-Op AFib - Diagnostic and Interventional Cardiology
1 Healthcare Stock on Our Buy List and 2 to Brush Off - Yahoo Finance
iRhythm Technologies (IRTC): Analyst Maintains Optimistic Outloo - GuruFocus
iRhythm (IRTC) Stock Trades Up, Here Is Why - Yahoo Finance
Wearable Blood Pressure Monitoring Patches Market CAGR 9.56% - openPR.com
Global Artificial Intelligence (AI) in Remote Patient - openPR.com
5 Revealing Analyst Questions From iRhythm’s Q1 Earnings Call - Yahoo Finance
Medical Device Leader with 40-Year Track Record and 6 Patents Joins Integer Board - Stock Titan
IRhythm Argues Patent Owner's Inaction Shouldn't Doom IPRs - Law360
iRhythm Technologies Announces Board Member Changes - The Globe and Mail
IRhythm IPR Denial Raises Key PTAB Discretion Questions - Law360
GameSquare (GAME) files equity & warrant offering; crypto plan flagged | IRTC SEC FilingForm 8-K - Stock Titan
iRhythm Technologies announces board changes as two directors retire - Investing.com Australia
iRhythm Urges Stewart to Reconsider and Clarify ‘Settled Expectations’ Basis for Discretionary Denial - IPWatchdog.com
iRhythm Technologies Announces Board Member Retirements and New Director Appointments | IRTC Stock News - GuruFocus
iRhythm Technologies Announces Board Member Retirements and New Director Appointments - The Manila Times
iRhythm Technologies Announces Retirement of Board Members and Appointment of New Directors - Quiver Quantitative
iRhythm Technologies Makes Crucial Board Changes: Two Veterans Exit as Digital Health Experts Step In - Stock Titan
iRhythm Technologies announces board changes as two directors retire By Investing.com - Investing.com UK
IPR Denial In IRhythm Should Not Set A Blanket Rule - Law360
Morgan Stanley Raises iRhythm (IRTC) Price Target, Maintains Overweight Rating - MSN
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 8, 2024 in iRhythm Technologies Lawsuit – IRTC - ACCESS Newswire
Irhythm Technologies Inc (IRTC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.39%
자본화:
|
볼륨(24시간):